Calidi Biotherapeutics, Inc.CLDINYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -31.75% |
| 2023 | 79.25% |
| 2022 | 55.26% |
| 2021 | 46.89% |
| 2020 | 0.00% |